Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 151

1.

A comparison of the efficacy of varenicline and bupropion and an evaluation of the effect of the medications in the context of the smoking cessation programme.

Benli AR, Erturhan S, Oruc MA, Kalpakci P, Sunay D, Demirel Y.

Tob Induc Dis. 2017 Feb 1;15:10. doi: 10.1186/s12971-017-0116-0.

2.

Smoking cessation practice among family doctors in Lithuania: a Survey.

Everatt R, Zolubiene E, Grassi MC.

Clin Ter. 2016 Sep-Oct;167(5):161-167.

PMID:
27845484
3.

Interventions to reduce harm from continued tobacco use.

Lindson-Hawley N, Hartmann-Boyce J, Fanshawe TR, Begh R, Farley A, Lancaster T.

Cochrane Database Syst Rev. 2016 Oct 13;10:CD005231. Review.

PMID:
27734465
4.

Sex Differences in Smoking Cessation Pharmacotherapy Comparative Efficacy: A Network Meta-analysis.

Smith PH, Weinberger AH, Zhang J, Emme E, Mazure CM, McKee SA.

Nicotine Tob Res. 2016 Jul 11. pii: ntw144. [Epub ahead of print] Review.

PMID:
27613893
5.

Combination Extended Smoking Cessation Treatment Plus Home Visits for Smokers With Schizophrenia: A Randomized Controlled Trial.

Brody AL, Zorick T, Hubert R, Hellemann GS, Balali S, Kawasaki SS, Garcia LY, Enoki R, Abraham P, Young P, McCreary C.

Nicotine Tob Res. 2017 Jan;19(1):68-76.

PMID:
27613888
6.

Smoking cessation for people with chronic obstructive pulmonary disease.

van Eerd EA, van der Meer RM, van Schayck OC, Kotz D.

Cochrane Database Syst Rev. 2016 Aug 20;(8):CD010744. doi: 10.1002/14651858.CD010744.pub2. Review.

PMID:
27545342
7.

Evaluating the effectiveness of smoking cessation in the management of COPD.

Temitayo Orisasami I, Ojo O.

Br J Nurs. 2016 Jul 28;25(14):786-91. doi: 10.12968/bjon.2016.25.14.786. Review.

PMID:
27467642
8.

Interventions for waterpipe tobacco smoking prevention and cessation: a systematic review.

Jawad M, Jawad S, Waziry RK, Ballout RA, Akl EA.

Sci Rep. 2016 May 11;6:25872. doi: 10.1038/srep25872.

9.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Lindson-Hawley N, Thomas KH, Fanshawe TR, Lancaster T.

Cochrane Database Syst Rev. 2016 May 9;(5):CD006103. doi: 10.1002/14651858.CD006103.pub7. Review.

PMID:
27158893
10.

Rapid assessment of the demand and supply of tobacco dependence pharmacotherapy in Uganda.

Kirenga BJ, Jones R, Muhofa A, Nyakoojo G, Williams S.

Public Health Action. 2016 Mar 21;6(1):35-7. doi: 10.5588/pha.15.0070.

11.

Combined pharmacotherapy and behavioural interventions for smoking cessation.

Stead LF, Koilpillai P, Fanshawe TR, Lancaster T.

Cochrane Database Syst Rev. 2016 Mar 24;3:CD008286. doi: 10.1002/14651858.CD008286.pub3. Review.

PMID:
27009521
12.

Drugs for smoking cessation.

Hartmann-Boyce J, Aveyard P.

BMJ. 2016 Feb 23;352:i571. doi: 10.1136/bmj.i571. No abstract available.

PMID:
26907501
13.

The safety of treatments for tobacco use disorder.

Little MA, Ebbert JO.

Expert Opin Drug Saf. 2016;15(3):333-41. doi: 10.1517/14740338.2016.1131817. Review.

PMID:
26715118
14.

Pharmacological interventions for promoting smoking cessation during pregnancy.

Coleman T, Chamberlain C, Davey MA, Cooper SE, Leonardi-Bee J.

Cochrane Database Syst Rev. 2015 Dec 22;(12):CD010078. doi: 10.1002/14651858.CD010078.pub2. Review.

PMID:
26690977
15.

Financial incentives to promote extended smoking abstinence in opioid-maintained patients: a randomized trial.

Sigmon SC, Miller ME, Meyer AC, Saulsgiver K, Badger GJ, Heil SH, Higgins ST.

Addiction. 2016 May;111(5):903-12. doi: 10.1111/add.13264.

PMID:
26638126
16.

Behavioral Counseling and Pharmacotherapy Interventions for Tobacco Cessation in Adults, Including Pregnant Women: A Review of Reviews for the U.S. Preventive Services Task Force [Internet].

Patnode CD, Henderson JT, Thompson JH, Senger CA, Fortmann SP, Whitlock EP.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Sep.

17.

Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation.

Stead LF, Koilpillai P, Lancaster T.

Cochrane Database Syst Rev. 2015 Oct 12;(10):CD009670. doi: 10.1002/14651858.CD009670.pub3. Review.

PMID:
26457723
18.

Smoking Cessation in Individuals With Serious Mental Illness: A Randomized Controlled Trial of Two Psychosocial Interventions.

Bennett ME, Brown CH, Li L, Himelhoch S, Bellack A, Dixon L.

J Dual Diagn. 2015;11(3-4):161-73. doi: 10.1080/15504263.2015.1104481.

PMID:
26457385
19.

Budgetary impact analysis on funding smoking-cessation drugs in patients with COPD in Spain.

Jiménez-Ruiz CA, Solano-Reina S, Signes-Costa J, de Higes-Martinez E, Granda-Orive JI, Lorza-Blasco JJ, Riesco-Miranda JA, Altet-Gomez N, Barrueco M, Oyagüez I, Rejas J; SESEPARAR’s Integrated Tobacco Research Program..

Int J Chron Obstruct Pulmon Dis. 2015 Sep 24;10:2027-36. doi: 10.2147/COPD.S87597.

20.

Effectiveness of multicomponent interventions in primary healthcare settings to promote continuous smoking cessation in adults: a systematic review.

Martín Cantera C, Puigdomènech E, Ballvé JL, Arias OL, Clemente L, Casas R, Roig L, Pérez-Tortosa S, Díaz-Gete L, Granollers S.

BMJ Open. 2015 Oct 1;5(10):e008807. doi: 10.1136/bmjopen-2015-008807. Review.

Items per page

Supplemental Content

Loading ...
Support Center